[HTML][HTML] Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3 …
…, K Bouiller, F Bounes-Vardon, D Boutoille… - The Lancet infectious …, 2022 - thelancet.com
Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …
[HTML][HTML] Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
…, S Borot, M Bourgeon-Ghittori, O Bourron, D Boutoille… - Diabetologia, 2020 - Springer
Methods We conducted a nationwide multicentre observational study in people with diabetes
hospitalised for COVID-19 in 53 French centres in the period 10–31 March 2020. The …
hospitalised for COVID-19 in 53 French centres in the period 10–31 March 2020. The …
French national cohort of first use of dalbavancin: a high proportion of off-label use
…, C Adjodah, N Baclet, O Bouchard, D Boutoille… - International journal of …, 2019 - Elsevier
Dalbavancin is a glycopeptide antibiotic with a long half-life, recently marketed in Europe for
skin and soft-tissue infections (SSTIs), but its real-life use is not well known. The aim of this …
skin and soft-tissue infections (SSTIs), but its real-life use is not well known. The aim of this …
[HTML][HTML] Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
…, R Lecomte, M Lefebvre, F Raffi, D Boutoille… - The Lancet …, 2021 - thelancet.com
Background Elevated proinflammatory cytokines are associated with greater COVID-19 severity.
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …
[HTML][HTML] Utility of hyposmia and hypogeusia for the diagnosis of COVID-19
…, C Biron, J Brochon, D Boutoille… - The Lancet Infectious …, 2020 - thelancet.com
1 Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N
Engl J Med 2020; published online Feb 28. DOI: 10.1056/NEJMoa2002032. 2 Hopkins C, …
Engl J Med 2020; published online Feb 28. DOI: 10.1056/NEJMoa2002032. 2 Hopkins C, …
[HTML][HTML] Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection
…, B Martha, D Burgot, D Boutoille… - … England Journal of …, 2021 - Mass Medical Soc
Background The management of prosthetic joint infection usually consists of a combination
of surgery and antimicrobial therapy. The appropriate duration of antimicrobial therapy for …
of surgery and antimicrobial therapy. The appropriate duration of antimicrobial therapy for …
Quality of life with diabetes-associated foot complications: comparison between lower-limb amputation and chronic foot ulceration
D Boutoille, A Féraille, D Maulaz… - Foot & ankle …, 2008 - journals.sagepub.com
Background: Diabetic foot complications result in huge costs for both society and individual
patients. Because our team performs numerous amputations each year for complicated …
patients. Because our team performs numerous amputations each year for complicated …
[HTML][HTML] Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
…, G Danic, G Gautier, P Gicquel, D Boutoille… - Journal of thrombosis …, 2020 - Springer
Coagulopathy in COVID-19 is a burning issue and strategies to prevent thromboembolic
events are debated and highly heterogeneous. The objective was to determine incidence and …
events are debated and highly heterogeneous. The objective was to determine incidence and …
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 …
Background Rezafungin is a next-generation, once-a-week echinocandin in development
for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive …
for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive …
Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial
…, F Dalle, B Denis, A Alanio, D Boutoille… - Clinical Infectious …, 2022 - academic.oup.com
Background Early diagnosis and prompt initiation of specific antifungal treatment are essential
for improving the prognosis of mucormycosis. We aimed to assess the performance of …
for improving the prognosis of mucormycosis. We aimed to assess the performance of …